<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="105930">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01957462</url>
  </required_header>
  <id_info>
    <org_study_id>CP239</org_study_id>
    <nct_id>NCT01957462</nct_id>
  </id_info>
  <brief_title>Investigation of Two Newly Developed 1-piece Convex Baseplates in Subjects With Ileostomy and Colostomy</brief_title>
  <official_title>Investigation of Two Newly Developed 1-piece Convex Baseplates in Subjects With Ileostomy and Colostomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coloplast A/S</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coloplast A/S</source>
  <oversight_info>
    <authority>Denmark: Danish Health and Medicines Authority</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the current investigation is to develop new soft and more flexible 1-piece convex
      ostomy products.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Actual">May 2013</completion_date>
  <primary_completion_date type="Actual">May 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>Degree of leakage</measure>
    <time_frame>14 days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>The degree of leakage is measured using a 32-point scale developed by Coloplast A/S</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">31</enrollment>
  <condition>Ileostomy - Stoma</condition>
  <condition>Colostomy - Stoma</condition>
  <arm_group>
    <arm_group_label>FirstColplast  Test V, Then Coloplast Test X</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The subject tests two experimental coloplast products in a randomised order. Coloplast Test product V and after cross over ColoplastTest product X</description>
  </arm_group>
  <arm_group>
    <arm_group_label>First Coloplast Test X, Then Coloplast Test V</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The subjects test the two experimental Coloplast products in a randomised order: Coloplast Test product X and after cross over Coloplast Test product V</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Coloplast Test V</intervention_name>
    <description>Coloplast Test product V is a newly developed 1-piece ostomy appliance</description>
    <arm_group_label>FirstColplast  Test V, Then Coloplast Test X</arm_group_label>
    <arm_group_label>First Coloplast Test X, Then Coloplast Test V</arm_group_label>
    <other_name>Coloplast 1-piece convex Test product V</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Coloplast Test X</intervention_name>
    <description>Coloplast Test X is a newly developed 1-piece ostomy appliance</description>
    <arm_group_label>FirstColplast  Test V, Then Coloplast Test X</arm_group_label>
    <arm_group_label>First Coloplast Test X, Then Coloplast Test V</arm_group_label>
    <other_name>Coloplast 1-piece convex Test product X</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Have given written informed consent and signed letter of authority.

          2. Are at least 18 years of age and have full legal capacity.

          3. Have had their ostomy (ileo- or colostomy) for at least 3 months.

          4. Have used a 1-piece convex ostomy product during the last month.

          5. Are willing and able to comply with investigation procedures.

          6. Have a ostomy with a diameter of 33 mm or less.

        Exclusion Criteria:

          1. Currently suffering from peristomal skin problems (i.e. bleeding or broken skin).

          2. Currently receiving or have within the past 2 month received radio- and/or
             chemotherapy.

          3. Currently receiving or have within the past month received local (peristomal area) or
             systemic steroid treatment.

          4. Are pregnant or breastfeeding.

          5. Have a loop ostomy (also called double-barrel or ostomy with two outlets).

          6. Known hypersensitivity toward any of the test products.

          7. Use irrigation during the investigation (flush the stoma with water).

          8. Participating in other interventional clinical investigations or have previously
             participated in this investigation.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Birte P Jakobsen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Coloplast A/S</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Coloplast A/S</name>
      <address>
        <city>Humleb√¶k</city>
        <zip>3050</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>October 1, 2013</lastchanged_date>
  <firstreceived_date>August 6, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
